You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Colorectal cancer survivors

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

B-Cell Non-Hodgkin Lymphoma, Multiple Myeloma Trial in Duarte (Best Practice, Cognitive Intervention, Comprehensive Geriatric

Recruiting
  • B-Cell Non-Hodgkin Lymphoma
  • Multiple Myeloma
  • Best Practice
  • +5 more
  • Duarte, California
    City of Hope Medical Center
Sep 19, 2023

NSCLC, Triple Negative Breast Cancer Trial in China (Datopotamab Deruxtecan (Dato-DXd))

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Triple Negative Breast Cancer
  • Datopotamab Deruxtecan (Dato-DXd)
  • Beijing, China
  • +27 more
Aug 11, 2022

CT-guided Pudendal Nerve Cryoneurolysis for Palliation of

Not yet recruiting
  • Malignancy-induced Pelvic Pain
  • CT-guided Pudendal Nerve Cryoneurolysis
  • Percutaneous image-guided cryoneurolysis
  • Tucson, Arizona
    University of Arizona
Oct 25, 2023

Distress, Depression, Grief Trial in San Francisco (Psilocybin, Modified brief Supportive Expressive Group Therapy)

Completed
Has Results
  • Distress
  • +2 more
  • Psilocybin
  • Modified brief Supportive Expressive Group Therapy
  • San Francisco, California
    University of California, San Francisco
Dec 13, 2020

Breast Cancer Trial in Boston, Ann Arbor (drug, procedure, radiation)

Active, not recruiting
Has Results
  • Breast Cancer
  • Boston, Massachusetts
  • +2 more
May 2, 2022

HER2-negative Breast Cancer Trial in Georgia, Mexico, United Kingdom (AZD9833)

Recruiting
  • HER2-negative Breast Cancer
  • Batumi, Georgia
  • +18 more
Jan 13, 2023

Head and Neck Carcinoma, Head and Neck Carcinoma of Unknown Primary, Hypopharyngeal Carcinoma Trial in Scottsdale, Rochester

Recruiting
  • Head and Neck Carcinoma
  • +10 more
  • Scottsdale, Arizona
  • +1 more
Jan 6, 2023

Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Invasive Ductal Breast Carcinoma Trial in Boston,

Active, not recruiting
  • Estrogen Receptor-positive Breast Cancer
  • +5 more
  • PI3K inhibitor BYL719
  • +3 more
  • Boston, Massachusetts
  • +1 more
Oct 14, 2022

Child-Pugh Class A, Child-Pugh Class B, Recurrent Hepatocellular Carcinoma Trial in Palo Alto, Sapporo (radiation, procedure,

Active, not recruiting
  • Child-Pugh Class A
  • +2 more
  • Stereotactic Body Radiation Therapy
  • +3 more
  • Palo Alto, California
  • +1 more
Sep 9, 2022

Antalgic Effects of Well-being Treatments in Cancer Care

Completed
  • Cancer
  • Cancer Pain
    • Valence, Drome, France
      Ch Valence
    Aug 5, 2022

    Breast Cancer Trial in Amman (Tattoo- Black Eye, clip- HydroMARK)

    Completed
    • Breast Cancer
    • Tattoo- Black Eye
    • clip- HydroMARK
    • Amman, Al 'A̅şimah, Jordan
      King Hussein Cancer Center
    Apr 26, 2023

    Implementation ofPharmacist-Based, Post-Chemotherapy Follow-up

    Recruiting
    • Cancer
    • Follow-up phone interview
    • Los Angeles, California
      Cedars-Sinai Medical Center
    Jul 20, 2023

    Healthy Volunteers Trial in San Francisco (Rosuvastatin, Rosuvastatin (Inhibitor arm), Eltrombopag)

    Recruiting
    • Healthy Volunteers
    • San Francisco, California
      Ucsf Ctsi Crc
    Nov 29, 2022

    Molecular Signature for Breast Cancer

    Not yet recruiting
    • Breast Cancer
    • Diagnostic assistance tool
    • (no location specified)
    Feb 2, 2023

    Upper Gastrointestinal Disorders, Lower Gastrointestinal Disorders, Hepatobiliary Cancer Trial in Southampton (Cardiopulmonary

    Recruiting
    • Upper Gastrointestinal Disorders
    • +2 more
    • Cardiopulmonary exercise test
    • Southampton, United Kingdom
      University Hospitals Southampton
    Oct 31, 2022

    Non-Invasive Biomarkers in Prostate Cancer Disease Management

    Recruiting
    • Prostate Cancer
    • Genomic and Histological Evaluation
    • Tampa, Florida
      Moffitt Cancer Center
    Nov 16, 2023

    Locally Advanced Pancreatic Cancer Trial in Shanghai (Tumor treating fields combined with Gemcitabine HCl and albumin binding

    Not yet recruiting
    • Locally Advanced Pancreatic Cancer
    • Tumor treating fields combined with Gemcitabine hydrochloride and albumin binding paclitaxel
    • Gemcitabine hydrochloride and albumin binding paclitaxel
    • Shanghai, Shanghai, China
      Huashan Hospital Affiliated to Fudan University
    Dec 8, 2022

    Active Pharmacovigilance of Anti-cancer Medicines

    Recruiting
    • Oncology
    • +2 more
      • Trieste, Italy
        IRCCS materno infantile Burlo Garofolo
      Apr 11, 2023

      Lung Cancer Trial in Oklahoma City (Enhanced lung cancer screening services)

      Recruiting
      • Lung Cancer
      • Enhanced lung cancer screening services
      • Oklahoma City, Oklahoma
        University of Oklahoma Health Sciences Center
      Nov 7, 2022

      NSCLC Trial in China (HSK40118)

      Recruiting
      • NSCLC
      • Beijing, Beijing, China
      • +11 more
      Sep 18, 2023

      Aggressive Non-Hodgkin Lymphoma, Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma, Ann Arbor Stage II

      Active, not recruiting
      • Aggressive Non-Hodgkin Lymphoma
      • +13 more
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center
      Aug 18, 2022

      Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in United States (Gemcitabine combined with

      Recruiting
      • Metastatic Pancreatic Cancer
      • Metastatic Pancreatic Adenocarcinoma
      • Gemcitabine combined with nab-paclitaxel
      • +4 more
      • La Jolla, California
      • +20 more
      Aug 18, 2022

      How Radium-223 Dichloride,Alpha Particle-emitting Radioactive

      Recruiting
      • Castration-resistant Prostate Cancer
      • Radium-223 dichloride (Xofigo, BAY88-8223)
      • Multiple Locations, Taiwan
        Many locations
      Aug 19, 2022

      Locally Advanced or Recurrent Metastatic HER-2 Negative Breast Cancer Trial in Shanghai (BL-B01D1, SI-B003)

      Not yet recruiting
      • Locally Advanced or Recurrent Metastatic HER-2 Negative Breast Cancer
      • Shanghai, Shanghai, China
        Fudan University Shanghai Cancer Center
      Sep 12, 2023

      Pediatric Cancer Trial in Saint Louis, Charlotte, Charleston (No intervention- registry only)

      Recruiting
      • Pediatric Cancer
      • No intervention- registry only
      • Saint Louis, Missouri
      • +2 more
      Apr 20, 2022